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Abstract
BACKGROUND: Induced pluripotent stem cells (iPSCs) were generated from somatic cells through reprogramming 
process. Peripheral blood mononuclear cells (PBMNCs) were an attractive source cells due to the ease of 
accessibility, need minimal invasive procedure, and can be stored frozen. Small-molecule compound VC6TFZ has 
been successfully reprogrammed iPSCs from mouse fibroblast, but it has not been proven in human.
AIM: This study aims to determine whether the small-molecule compound VC6TFZ can induce pluripotency of 
PBMNC to generate iPSCs.
METHODS: Mononuclear cells were isolated from peripheral venous blood using centrifugation gradient density 
method. Mononuclear cells were cultured for 6 days in expansion medium and 48 h using hanging drop method. 
Pluripotency induction process using small-molecule compound VC6TFZ was done in 14 days then the medium 
changed to 2i medium for 7 days. Identification of iPSCs based on colony morphology and expression of pluripotency 
marker OCT4 and SOX2.
RESULTS: Colonies appeared on day 9 of reprogramming process. These colonies had round, large, and cobble 
stone morphology like embryonic stem cell. These colonies had positive expression of pluripotency markers OCT4 
and SOX2. All experimental groups had significantly higher expression of OCT4 and SOX2 than control group.
CONCLUSION: Small-molecule compound VC6TFZ could induce pluripotency of human PBMNC to generate iPSCs.
Introduction
Pluripotent stem cells play an important role in 
regenerative medicine due to their ability to differentiate 
into all cell types and unlimited self-renewal. The common 
source of pluripotent stem cells was embryonic stem 
cells (ESCs) which are generated from inner cell mass 
of embryo at blastocyst stage. The use of ESCs was 
controversial due to some ethical issue related to embryo 
destruction, risk of immune rejection, and limited source 
due to embryo origin. Induced pluripotent stem cells 
(iPSCs) have been an alternative source of pluripotent 
stem cells which tackled the ethical issue because it 
originates from somatic cells. Potential application of 
iPSCs such as provides cells for cell transplantation 
therapy, disease modeling, and drug screening [1].
iPSCs were generated from somatic cells by 
reprogramming process using various reprogramming 
factors. Skin fibroblast cells were the first source cells and 
still being the most frequently used [2], [3]. Skin biopsy 
procedures were uncomfortable, leave scar tissue, and 
require a long time for fibroblast cell expansion, limiting 
the use of fibroblasts as a source of iPSCs. Other source 
cells were keratinocytes, mesenchymal stem cells from 
adipose tissue, cord blood cells, and peripheral blood 
cells. Peripheral blood cells were one of the attractive 
sources of iPSCs because easy to collect, minimally 
invasive, and can be stored in a frozen form [4].
Blood cells were continuously replaced by 
stem cells in bone marrow, made these cells less 
susceptible to environment-associated point mutation 
than skin which exposed to ultraviolet light. The quality 
of iPSCs derived from peripheral blood mononuclear 
cell (PBMNC) and fibroblasts was equivalent and 
difficult to distinguish from ESCs. iPSCs derived 
from PBMNC were comparable to ESCs in terms of 
morphology, expression of surface antigens, activation 
of endogenous pluripotent genes, DNA methylation, 
and differentiation abilities [5].
Since its discovery, iPSCs were generated 
through transduction of exogenous transcription 
factors OCT4, SOX2, Klf4, and c-Myc (OSKM) into the 
nucleus of somatic cells transferred using retroviruses 
[2], [3]. The reprogramming process which used 
exogenous transcription factors with integrative systems 
associated with low efficiency, risk of mutagenesis, and 
tumorogenesis thereby limiting their use for clinical 
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applications. Various approaches were made to improve 
the efficiency and safety of iPSCs for clinical applications, 
one of the strategies was the use of small molecules [6].
At present, small molecules have an important 
role in reprogramming. Small molecules that worked 
on signaling pathways, epigenetic modifications, and 
metabolic processes had been widely used to improve 
reprogramming efficiency using exogenous transcription 
factors. The combination of several small molecules 
could induce pluripotency despite without exogenous 
transcription factors [7]. Small molecules were cell 
permeable and non-immunogenic. Small molecules 
were more cost efficient, easy to manufacture, can be 
stored, and standardized. Another advantage was that 
it did not involve genetic manipulation so it was safer, 
had fast biological effect, reversible, the effect can be 
controlled by modifying dosage and combinations [8].
VC6TFZ was a combination of small molecules 
consisting of valproic acid (VPA), CHIR990210 
(CHIR), 616452 (Repsox), tranylcypromine, forskolin, 
3-deazaneplanocin (DZnep), and 4-[(E)-2-(5,6,7,8-
Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-
propenyl]benzoic acid, or also called TTNPB. The 
combination of these small molecules could induce 
pluripotency in mouse embryonal fibroblasts (MEFs) 
with higher efficiency than the Yamanaka protocol that 
used exogenous transcription factors (0.02% vs. 0.001–
0.01%) [9]. This study was the first study aimed to prove 
whether the small-molecule compound VC6TFZ could 
induce pluripotency in human PBMNC.
Methods
This study was a post-test control group only 
design in vitro study. This study protocol, as shown in 
Figure 1, consisted of several steps including PBMNC 
isolation, PBMNC culture, pluripotency induction using 
small molecules, and iPSCs identification. Blood samples 
were derived from a 31-year-old female volunteer.
Figure 1: Study protocol
PBMNCs isolation
Blood was collected into heparin-coated tubes. 
Collected blood was diluted with 5 cc phosphate-buffered 
saline (PBS) and centrifuged through a Ficoll gradient 
for 30 min at 1600 × g. PBMNCs were collected and 
transferred to a new tube and add 10 cc PBS, centrifuged 
for 5 min at 2000 × g. Supernatant was aspirated and 
resuspend at 10 cc PBS.
Peripheral blood mononuclear culture
PBMNCs were cultured at Roswell Park 
Memorial Institute (RPMI) medium enriched with 
L-glutamine 1 mL/100 mL, ITS 1 mL/100 mL, FGF 5 ng/uL, 
ascorbic acid 5 mg/100 mL, GMCSF 50 uL/100 mL, and 
dexamethasone 100 uL/100 mL. Mononuclear cells were 
cultured for 6 days, and medium was changed every 
3 days. After 6 days culture at RPMI medium, PBMNCs 
were cultured using hanging drop method for 2 days. 
Hanging drop cultured was done by dripping the cell 
suspension using tip of the pipette at 5 cm Petri dish cover. 
The cover dish then reversed, continued with incubating 
cells at 37° C CO2 for 48 hours without adding medium.
Pluripotency induction using small-
molecule compound VC6TFZ
Three drops of mononuclear cell suspension 
were transferred to M-24 well plate pre-coated with 
vitronectin overnight and feeder cells. Feeder cells 
were made from mitosis-inactivated rabbit adipose 
mesenchymal cells using mitomycin-C 2 μg/mL for 
30 min. Add ReproTesR medium which contained small-
molecule VC6TF. At day 7, DZnep was added. Cells were 
exposed to small molecules for 14 days. The medium was 
changed every 4 days. On day 14, VC6TFZ was changed 
to 2i medium (PD0325901 and CHIR) for 7 days.
The cells were grouped into four groups. 
Group 1 (P1) was the control group, which was not 
exposed to small molecule. Group 2 (P2) was the 
experimental groups which exposed to small-molecule 
dosage VPA 0.5 mM, CHIR 5 uM, 616452 5 uM, 
tranylcypromine 2.5 uM, FSK 20 uM, DZnep 20 nM, 
and TTNPB 5 uM. Group 3 (P3) was the experimental 
groups which exposed to small-molecule dosage VPA 
0.75 mM, CHIR 10 uM, 616452 7.5 uM, tranylcypromine 
5 uM, FSK 40 uM, DZnep 50 nM, and TTNPB 5 uM. 
Group 4 (P4) was the experimental groups which 
exposed to small-molecule VPA 1 mM, CHIR 20 uM, 
616452 10 uM, tranylcypromine 10 uM, FSK 60 uM, 
DZnep 100 nM, and TTNPB 5 uM.
iPSCs identification
Identification of iPSCs was done by morphology 
identification and expression of pluripotency markers 
(SOX2 and OCT4). iPSC colonies had large 
characteristics, tight and clear border, and cobble 
stone-like appearance. In iPSC colonies, cells had a 
small size with a large ratio of cytoplasmic nuclei.
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Immunohistochemical staining
Cells were fixed with methanol for 10 min, 
then wash with cold PBS 2 times. The cells were then 
stabilized with 0.25% Triton X-100 on PBS for 10 min 
at room temperature. The cells were washed with PBS 
3 times for 5 min. Cells were incubated with 1% bovine 
serum albumin (BSA) in phosphate-buffered saline with 
Tween (PBST) for 30 min. Cells were then incubated in 
antibody solution (OCT4 and SOX2) in 1% BSA in PBST 
in humidified chamber for 1 h at room temperature or 
overnight at 4°C. The procedure continued with washing 
the cells for 5 minutes with PBS, repeated for 3 times. 
The cell was then incubated with the Alexa Fluor 488 
goat anti-mouse IgG secondary antibody. Fluorescent 
signal is then viewed under a microscope.
Statistical analysis
Collected data were coded, tabulated, and 
statistically analyzed using the SPSS version 24. OCT4 
and SOX2 expressions will be presented mean±SD. 
Data normality test was done using Kolmogorov–
Smirnov test. Differences in OCT4 expression and 
SOX2 expression between the four groups will be 
analyzed by one-way ANOVA test if the data were 
normally distributed and Kruskal–Wallis if the data were 
not normally distributed. The difference was said to be 
significant if p < 0.05.
Results
iPSCs like colony were appeared at day 9 
after cells were exposed to small molecule. Colonies 
had large and round morphology with cobble stone-like 
appearance (Figure 2).
Figure 2: Changed of colonies morphology at day 0–day 21
All colonies were expressed pluripotency 
markers. OCT4 expression was found in all treatment 
groups with the strongest expression in P3 group. 
Cells that had strong expressions of OCT4 will glow 
bright green (Figure 3), the degree of luminance will 
Figure 3: OCT4 expression in each group
be measured quantitatively using ImageJ software. 
Significant differences were found between the P3 and 
P4 groups with the control group (p = 0.000, p = 0.022), 
whereas between the P2 group and the control, there was 
no significant difference (p = 0.116) as shown in Table 1.
Table 1: Comparison of OCT4 expression between groups
Control group VC6TFZ experimental group mean ± SD OCT4 p
30.082 ± 5.93 P2: 49.905 ± 13.49 0.121
P3: 182.185 ± 52.70 0.000
P4: 86.898 ± 67.04 0.022
All colonies also expressed SOX2 markers 
(Figure 4). 
Figure 4: SOX2 expression in each group
The mean SOX2 expression was stronger in 
all treatment groups compared to the control group with 
the strongest expression found in the P3 group. There 
was a significant difference between the control group 
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with P3 and P4 (p = 0.028, p = 0.006), but there was no 
significant difference between the control group with P2 
(p = 0.116) as shown in Table 2.
Table 2: Comparison of SOX2 expression between groups
Control group VC6TFZ experimental groups mean±SD SOX2 p
44.206 ± 35.751 P2: 142.441 ± 129.542 0.116
P3: 227.992 ± 123.736 0.028
P4: 171.784 ± 61.56439 0.006
Discussion
iPSCs was generated from somatic cells through 
the reprogramming process. These stem cells had the 
ability to differentiate into all cell types and unlimited 
self-renewal abilities. This property made these cells 
had potential as cell sources for cell transplantation 
therapy, disease modeling, and drug screening [10]. 
The first and most widely used cell source for the 
generation of iPSCs was skin fibroblast cells [4], [8]. 
This study used PBMNNC as a source for iPSCs due 
to their ease of accessibility, minimally invasive, and 
less susceptible to point mutation [5]. Many research 
had been done to generate iPSCs from PBMNC, where 
these iPSCs had similar quality as iPSCs derived 
from fibroblasts [11], [12], [13]. The previous studies 
used Sendai virus, Lentivirus, and episomal vector for 
pluripotency induction in PBMNC [11], [12], [13], [14]. 
This study was the first study that used small molecules 
to induce human PBMNC pluripotency.
In this study, we found that small-molecule 
compound VC6TFZ could induce pluripotency in human 
PBMNC. It was proven by the formation of colonies 
that resembled iPSCs morphology and the expression 
of pluripotency markers (OCT4 and SOX2). In this 
study, we found a colony that began to appear on the 
3rd day of induction and increasingly enlarge on day 9. 
The colonies had round morphology, cobble stone like, 
and clear edges. This colonies morphology resembles 
iPSCs as described in the guidelines and techniques 
for the generation of iPSCs [15].
The colonies in this study express pluripotency 
markers, OCT4 and SOX2. The expressions of each 
marker were analyzed quantitatively using ImageJ 
software, which obtained higher expressions in all 
treatment groups compared to the control group. 
Statistically, there were significant differences between 
the control group and the P3 and P4 groups in OCT4 
expression (p = 0,000; p = 0.022) and SOX2 (p = 0.028; 
p = 0.006). This indicates the most optimal expression 
of OCT4 and SOX2 at small-molecule P3 and P4. This 
indicates that the effect of small molecule on the success of 
reprogramming was dose dependent [9], [16]. The key for 
reprogramming successful with small molecules was the 
concentration and combination of small molecules. Small 
molecules could be cytotoxic at certain concentrations so 
that at higher doses, the reprogramming efficiency was 
sometimes even lower [16].
The protocol we used in this study was different 
from the previous studies, where the induction was 
done in only 21 days, faster than the Hou et al. In Hou’s 
study, GFP-positive colonies began to appear around 
day 10–12, while in this study, the colonies appeared 
earlier at day 6. This was likely due to the optimized 
culture method and the hanging drop culture method. 
Optimization of PBMNC culture plays an important role 
in the reprogramming process. In this study, we cultured 
PBMNC for 6 days in an expansion medium. During 
culture period, the longer duration the more number of 
dead cells, but the number of living cells remains constant, 
so the optimal duration of culture time was needed. This 
6-day duration was based on research conducted by Gu 
et al. where this study showed that the 6-day culture time 
shows the number of colonies that most expressed TRA 
1-60 and AP compared to days 4.8 or 10 [17].
Hanging drop culture method allows the 
formation of colonies through cell aggregation induced 
by gravity [18]. The accumulation of cells in the drop 
allows the formation of spheroidal colonies. Spheroid 
colonies that were formed can produce extracellular 
matrices and environments that resemble living tissue. 
Inside the drop cells adhere to each other by holding 
on the resulting matrix. Intercell interactions and 
interactions between cells and extracellular matrix were 
better with this method [19], [20]. This method also 
allows more efficient diffusion of growth factors and 
metabolic waste disposal [21].
In this research, small-molecule compound 
VC6TFZ was combination of VPA, CHIR, 616452, 
tranylcypromin, FSK, and DZnep. The VC6TFZ 
combination was first discovered by Hou et al. after 
screening 10,000 small molecules. Hou has succeeded 
in generating iPSCs derived from MEF using VC6TFZ 
without any exogenous transcription factors [9].
The CHIR, FSK, and 616452 (Repsox) 
components induce the expression of Sall4 and SOX2 
pluripotent genes in the early phase of the cellular 
reprogramming process. Concomitant overexpression 
between Sall4 and SOX2 can activate OCT4 promoter-
driven luciferase reporter so that it is sufficient to 
replace C6F for OCT4 induction. Expression of 
OCT4 increased significantly with the addition of 
DZnep. DZnep was important to stimulate OCT4 
expression, but not other pluripotent genes. As a 
S-adenosylhomocysteine hydrolase (SAH) hydrolase 
inhibitor, DZnep increased the concentration ratio 
of SAH and S-adenosylmethionine (SAM), thereby 
reducing the SAM-dependent cellular methylation 
process. The role of DZNep in OCT4 activation occurs 
through decreased DNA and H3K9 methylation in the 
OCT4 promoter region. OCT4 and SOX2 then activate 
other pluripotent genes such as Nanog. SOX2, OCT4, 
and Nanog activated each other to form a pluripotency 
circuit that maintains the pluripotent nature of a cell. 
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OCT4 expression expressed in somatic cells through 
various epigenetic modifications, opened with a 
chemical cellular reprogramming process using the 
DZnep epigenetic modulator, and stimulated by C6F-
induced expression Sox2-Sall4 [9].
One of the challenges in reprogramming PBMNC 
was that these cells had non-adherent nature [13]. To 
overcome this problem, we coated the well walls using 
vitronectin and feeder cells that enable the PBMNC 
attachment on the well. This attachment was important 
to avoid cell lost during medium replacement. Previously, 
we only used vitronectin to coat the well, but the cells were 
still not adherent so we decided to make feeder cells. 
This feeder cell produces stemness-supporting factors 
that prevent spontaneous differentiation. This feeder cell 
produced adhesion molecules and extracellular matrix 
that increases attachment of iPSCs which supports 
growth and survival [22], [23].
Other feeder cells types used for in ESC/iPSCs 
production such as MEFs, STO cells, and SNL 76/7 cells. 
The most widely used was MEF proliferation-inactivated 
using mitomycin-C or gamma X-ray. Inactivation of 
mitosis or MEF irradiation stimulated the expression 
of several proteins such as Wnt-3 that contributed to 
molecular mechanisms in maintaining pluripotency. 
MEFs produced various proteins such as transforming 
growth factor beta 1, activin A, bone morphogenetic 
protein-4, and pleitrophin (heparin-binding growth 
factor). Vitronectin was an extracellular matrix protein 
that was rich in peptide arginine-glycine-aspartate (RGD) 
needed for integrin-mediated cell adhesion and growth 
through cellular pathway activation. Vitronectin also 
supports self-renewal and pluripotency from ESC [22]. 
In this study, we used rabbit adipose mesenchymal cells 
which mitosis-inactivated using 2 μg/mL mitomycin-C 
for 30 min. This dose was smaller than the dose used 
in the literature for MEFs which was 10 μg/mL [23], [24].
Conclusion
This was the first study that showed small-
molecule compound VC6TFZ could induce pluripotency 
in human PBMNC. Further research was needed to 
analyze molecular profile, differentiation, and self-
renewal ability of these cells. For clinical application, 
the safety profile related to the risk of tumorogenesis 
and genetic instability also needed further investigation.
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